Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits

Qunsheng Dai, Ari D. Silverstein, Mark G. Davies, Per Otto Hagen, Craig F. Donatucci, Brian H. Annex

Research output: Contribution to journalArticle

Abstract

Purpose: Hypercholesterolemia causes erectile dysfunction that is associated with abnormalities in vascular smooth muscle and endothelial cells. We determined the effects of basic fibroblast growth factor (bFGF) on corporeal tissue in hypercholesterolemic rabbits. Materials and Methods: A total of 16 New Zealand White rabbits were fed a 1% cholesterol diet for 6 weeks and were randomly divided into 3 groups. Group 1 (5 rabbits) received 2.5 μg recombinant bFGF intravenously once and again 3 weeks later. Group 2 (6 rabbits) received 2.5 μg bFGF intravenously once and placebo 3 weeks later. Group 3 (5 rabbits) received placebo intravenously each time. Rabbits were continuously fed a 1% cholesterol diet and sacrificed 3 weeks after the last treatment. Smooth muscle, endothelial cell and collagen content were assessed by immunohistochemistry and histochemical staining of corporeal tissue. Vascular endothelial growth factor (VEGF) protein and mRNA expression were assessed by enzyme-linked immunosorbent assay and reverse transcriptase-polymerase chain reaction. Results: Corporeal smooth muscle content was greater in groups 1 and 2 (35.24% ± 4.25% and 24.79% ± 3.39%, p <0.01) vs group 3 (19.68% ± 2.94%, vs groups 1 and 2 p <0.001 and <0.05, respectively). Endothelial cell and collagen content were similar among the groups. VEGF protein was increased in group 1 vs group 2 (97.90 ± 26.00 vs 57.03 ± 14.99 pg/ml, p <0.01) and vs group 3 (39.93 ± 15.08, p <0.01). There was no statistical difference between groups 2 and 3. VEGF mRNA expression was similar among the groups. Conclusions: Systemic bFGF increases smooth muscle content and VEGF protein in hypercholesterolemic rabbit corporeal tissue.

Original languageEnglish (US)
Pages (from-to)664-668
Number of pages5
JournalJournal of Urology
Volume170
Issue number2 I
DOIs
StatePublished - Aug 1 2003

Fingerprint

Fibroblast Growth Factor 2
Rabbits
Vascular Endothelial Growth Factor A
Endothelial Cells
Smooth Muscle Myocytes
Smooth Muscle
Collagen
Cholesterol
Placebos
Diet
Messenger RNA
Proteins
Erectile Dysfunction
Hypercholesterolemia
Reverse Transcriptase Polymerase Chain Reaction
Vascular Smooth Muscle
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
Staining and Labeling

Keywords

  • Angiogenic growth factors
  • Endothelium
  • Fibrosis
  • Impotence
  • Penis
  • Rabbits

ASJC Scopus subject areas

  • Urology

Cite this

Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. / Dai, Qunsheng; Silverstein, Ari D.; Davies, Mark G.; Hagen, Per Otto; Donatucci, Craig F.; Annex, Brian H.

In: Journal of Urology, Vol. 170, No. 2 I, 01.08.2003, p. 664-668.

Research output: Contribution to journalArticle

Dai, Qunsheng ; Silverstein, Ari D. ; Davies, Mark G. ; Hagen, Per Otto ; Donatucci, Craig F. ; Annex, Brian H. / Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. In: Journal of Urology. 2003 ; Vol. 170, No. 2 I. pp. 664-668.
@article{4c904cc4d5d04d5dace03abcc12f0bc4,
title = "Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits",
abstract = "Purpose: Hypercholesterolemia causes erectile dysfunction that is associated with abnormalities in vascular smooth muscle and endothelial cells. We determined the effects of basic fibroblast growth factor (bFGF) on corporeal tissue in hypercholesterolemic rabbits. Materials and Methods: A total of 16 New Zealand White rabbits were fed a 1{\%} cholesterol diet for 6 weeks and were randomly divided into 3 groups. Group 1 (5 rabbits) received 2.5 μg recombinant bFGF intravenously once and again 3 weeks later. Group 2 (6 rabbits) received 2.5 μg bFGF intravenously once and placebo 3 weeks later. Group 3 (5 rabbits) received placebo intravenously each time. Rabbits were continuously fed a 1{\%} cholesterol diet and sacrificed 3 weeks after the last treatment. Smooth muscle, endothelial cell and collagen content were assessed by immunohistochemistry and histochemical staining of corporeal tissue. Vascular endothelial growth factor (VEGF) protein and mRNA expression were assessed by enzyme-linked immunosorbent assay and reverse transcriptase-polymerase chain reaction. Results: Corporeal smooth muscle content was greater in groups 1 and 2 (35.24{\%} ± 4.25{\%} and 24.79{\%} ± 3.39{\%}, p <0.01) vs group 3 (19.68{\%} ± 2.94{\%}, vs groups 1 and 2 p <0.001 and <0.05, respectively). Endothelial cell and collagen content were similar among the groups. VEGF protein was increased in group 1 vs group 2 (97.90 ± 26.00 vs 57.03 ± 14.99 pg/ml, p <0.01) and vs group 3 (39.93 ± 15.08, p <0.01). There was no statistical difference between groups 2 and 3. VEGF mRNA expression was similar among the groups. Conclusions: Systemic bFGF increases smooth muscle content and VEGF protein in hypercholesterolemic rabbit corporeal tissue.",
keywords = "Angiogenic growth factors, Endothelium, Fibrosis, Impotence, Penis, Rabbits",
author = "Qunsheng Dai and Silverstein, {Ari D.} and Davies, {Mark G.} and Hagen, {Per Otto} and Donatucci, {Craig F.} and Annex, {Brian H.}",
year = "2003",
month = "8",
day = "1",
doi = "10.1097/01.ju.0000065247.55066.ad",
language = "English (US)",
volume = "170",
pages = "664--668",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2 I",

}

TY - JOUR

T1 - Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits

AU - Dai, Qunsheng

AU - Silverstein, Ari D.

AU - Davies, Mark G.

AU - Hagen, Per Otto

AU - Donatucci, Craig F.

AU - Annex, Brian H.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Purpose: Hypercholesterolemia causes erectile dysfunction that is associated with abnormalities in vascular smooth muscle and endothelial cells. We determined the effects of basic fibroblast growth factor (bFGF) on corporeal tissue in hypercholesterolemic rabbits. Materials and Methods: A total of 16 New Zealand White rabbits were fed a 1% cholesterol diet for 6 weeks and were randomly divided into 3 groups. Group 1 (5 rabbits) received 2.5 μg recombinant bFGF intravenously once and again 3 weeks later. Group 2 (6 rabbits) received 2.5 μg bFGF intravenously once and placebo 3 weeks later. Group 3 (5 rabbits) received placebo intravenously each time. Rabbits were continuously fed a 1% cholesterol diet and sacrificed 3 weeks after the last treatment. Smooth muscle, endothelial cell and collagen content were assessed by immunohistochemistry and histochemical staining of corporeal tissue. Vascular endothelial growth factor (VEGF) protein and mRNA expression were assessed by enzyme-linked immunosorbent assay and reverse transcriptase-polymerase chain reaction. Results: Corporeal smooth muscle content was greater in groups 1 and 2 (35.24% ± 4.25% and 24.79% ± 3.39%, p <0.01) vs group 3 (19.68% ± 2.94%, vs groups 1 and 2 p <0.001 and <0.05, respectively). Endothelial cell and collagen content were similar among the groups. VEGF protein was increased in group 1 vs group 2 (97.90 ± 26.00 vs 57.03 ± 14.99 pg/ml, p <0.01) and vs group 3 (39.93 ± 15.08, p <0.01). There was no statistical difference between groups 2 and 3. VEGF mRNA expression was similar among the groups. Conclusions: Systemic bFGF increases smooth muscle content and VEGF protein in hypercholesterolemic rabbit corporeal tissue.

AB - Purpose: Hypercholesterolemia causes erectile dysfunction that is associated with abnormalities in vascular smooth muscle and endothelial cells. We determined the effects of basic fibroblast growth factor (bFGF) on corporeal tissue in hypercholesterolemic rabbits. Materials and Methods: A total of 16 New Zealand White rabbits were fed a 1% cholesterol diet for 6 weeks and were randomly divided into 3 groups. Group 1 (5 rabbits) received 2.5 μg recombinant bFGF intravenously once and again 3 weeks later. Group 2 (6 rabbits) received 2.5 μg bFGF intravenously once and placebo 3 weeks later. Group 3 (5 rabbits) received placebo intravenously each time. Rabbits were continuously fed a 1% cholesterol diet and sacrificed 3 weeks after the last treatment. Smooth muscle, endothelial cell and collagen content were assessed by immunohistochemistry and histochemical staining of corporeal tissue. Vascular endothelial growth factor (VEGF) protein and mRNA expression were assessed by enzyme-linked immunosorbent assay and reverse transcriptase-polymerase chain reaction. Results: Corporeal smooth muscle content was greater in groups 1 and 2 (35.24% ± 4.25% and 24.79% ± 3.39%, p <0.01) vs group 3 (19.68% ± 2.94%, vs groups 1 and 2 p <0.001 and <0.05, respectively). Endothelial cell and collagen content were similar among the groups. VEGF protein was increased in group 1 vs group 2 (97.90 ± 26.00 vs 57.03 ± 14.99 pg/ml, p <0.01) and vs group 3 (39.93 ± 15.08, p <0.01). There was no statistical difference between groups 2 and 3. VEGF mRNA expression was similar among the groups. Conclusions: Systemic bFGF increases smooth muscle content and VEGF protein in hypercholesterolemic rabbit corporeal tissue.

KW - Angiogenic growth factors

KW - Endothelium

KW - Fibrosis

KW - Impotence

KW - Penis

KW - Rabbits

UR - http://www.scopus.com/inward/record.url?scp=0038168385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038168385&partnerID=8YFLogxK

U2 - 10.1097/01.ju.0000065247.55066.ad

DO - 10.1097/01.ju.0000065247.55066.ad

M3 - Article

C2 - 12853852

AN - SCOPUS:0038168385

VL - 170

SP - 664

EP - 668

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2 I

ER -